Evidence map›Paper›PMID 32918127›Full record

ArticleCancer immunology, immunotherapy : CII2021

A systematic scoping review on natural killer cell function in colorectal cancer.

Fiona S W Reid, Natasha Egoroff, Peter G Pockney, Stephen R Smith

Open access · greenAbstract readScoping Review
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Lactylation and antitumor immunity.Frontiers in immunology · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Fiona S W ReidSurgical Services, HRMC, John Hunter Hospital, Locked Bag 1, New Lambton, Newcastle, NSW, 2310, Australia. Fiona.reid@wh.org.au.ORCID http://orcid.org/0000-0001-6341-257X
Natasha EgoroffSurgical Services, HRMC, John Hunter Hospital, Locked Bag 1, New Lambton, Newcastle, NSW, 2310, Australia.
Peter G PockneySurgical Services, HRMC, John Hunter Hospital, Locked Bag 1, New Lambton, Newcastle, NSW, 2310, Australia.
Stephen R SmithSurgical Services, HRMC, John Hunter Hospital, Locked Bag 1, New Lambton, Newcastle, NSW, 2310, Australia.
John Hunter Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNatural Killer (NK) cells are a vital part of immune surveillance and have been implicated in colorectal cancer development and prognosis. This systematic review aims to distil the literature on NK cells as it relates to colorectal cancer.

methodsAll published studies over 10 years relating to NK cells and colorectal cancer were reviewed. All studies publishing in English, searchable via pubmed or through reference review and reporting directly on the nature or function of NK cells in colorectal cancer patients were included. Outcomes were determined as alterations or new information regarding NK cells in colorectal cancer patients.

resultsNatural killer cells may be implicated in the development of colorectal cancer and may play a role in prognostication of the disease. NK cells are altered by the treatment (both surgical and medical) of colorectal cancer and it seems likely that they will also be a target for manipulation to improve colorectal cancer survival.

conclusionsNK cell morphology and function are significantly affected by the development of colorectal cancer. Observation of NK cell changes may lead to earlier detection and better prognostication in colorectal cancer. Further study is needed into immunological manipulation of NK cells which may lead to improved colorectal cancer survival.

Indexed as

AnimalsColorectal NeoplasmsDisease SusceptibilityGenetic Predisposition to DiseaseHumansImmunologic SurveillanceKiller Cells, NaturalNeoplastic Cells, CirculatingPrognosisRisk AssessmentRisk FactorsColorectal neoplasmsImmunologic surveillanceKiller cellsMESHNatural

Identifiers

PMID32918127
PMCPMC10992123
OpenAlexW3085470020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.